Integral Health Asset Management »

Bioage Labs shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of Bioage Labs (BIOA) shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in Bioage Labs

Tip: Access up to 7 years of quarterly data

All positions including Bioage Labs held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioage Labs by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.4M 300k 24.51

More positions owned by Integral Health Asset Management

Revolution Medicines (RVMD)
Insmed Com Par $.01 (INSM)
Cytokinetics Com New (CYTK)
CVS Caremark Corporation (CVS)
Edgewise Therapeutics (EWTX)
Vera Therapeutics Cl A (VERA)
Axsome Therapeutics (AXSM)
Cardinal Health (CAH)
Roivant Sciences SHS (ROIV)
Rhythm Pharmaceuticals (RYTM)
Edwards Lifesciences (EW)
Alignment Healthcare (ALHC)
Merck & Co (MRK)
Novo-nordisk A S Adr (NVO)
Quest Diagnostics Incorporated (DGX)

View all positions for Integral Health Asset Management

Top funds holding Bioage Labs

AH Capital Management
BlackRock
Cormorant Asset Management
Sofinnova Ventures
Jupiter Topco
Henderson Group
Octagon Capital Advisors
RA Capital Management
MPM Oncology Impact Management
Vanguard Capital Management
Polar Capital Holdings
Braidwell
Geode Capital Management
State Street Corporation
Sands Capital Ventures

View all funds holding Bioage Labs